This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
ProMab
product type :
antibody
product name :
Mouse Monoclonal Antibody to FLT4
catalog :
30060
quantity :
100μl
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, ELISA
product information
Catalog :
30060
Title :
Mouse Monoclonal Antibody to FLT4
Species :
Human
Clone :
4H4;
lsotype :
Mouse IgG1
Size :
100μl
Storage :
4℃; -20℃ for long term storage
Description :
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. Tissue specificity: Placenta, lung, heart, and kidney, does not seem to be expressed in pancreas and brain. VEGFR-3 is induced in all endothelial cells (EC’s) during early embryogenesis, and its expression eventually disappears from the vascular endothelial cells of adult tissues. VEGFR-3 is constitutively expressed in the adult lymphatic endothelium. Although VEGFR-3 is not expressed in adult blood vessels, it is induced in vascular endothelial cells of tumor-bearing tissues.VEGFR-3 expression in adults is largely restricted to the endothelial cells of the lymphatic system, and high endothelial venules (HEV).
Immunogen :
Purified recombinant fragment of human FLT4 expressed in E. Coli. ;
Formulation :
Ascitic fluid containing 0.03% sodium azide. ;
Applications :
ELISA: 1/10000; WB: 1/500 - 1/2000
References :
1. Prostate. 2009 Jun 15;69(9):982-90. ; 2. J Cell Sci. 2009 Sep 15;122(Pt 18):3358-64. ; 3. Oncol Rep. 2009 Nov;22(5):1093-100.
Type :
Monoclonal Antibody
MW :
145kDa
Aliases :
PCL; FLT41; LMPH1A; VEGFR3; FLT4
company information
ProMab
5221 Central Avenue, Suite 200
Richmond, CA 94804
Richmond, CA 94804
info@promab.com
http://www.promab.com1-866-339-0871
headquarters: USA
questions and comments